Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAEAN: Erythropoietin for Neonatal HIE
NCT03079167Phase 3Completed
- Sponsor
- University of Sydney
- Start
- May 2016
- Primary completion
- Nov 2023
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 3
01
Overview
A Phase 3 trial of epoetin alfa in hypoxic-ischemic encephalopathy (HIE), sponsored by University of Sydney. Started May 2016; status: completed.
02
Drugs
epoetin alfa
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT03079167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03079167.